Enoblituzumab is a monoclonal antibody designed for the treatment of cancer.
Statement On A Nonproprietary Name Adopted By The USAN Council - Enoblituzumab
''American Medical Association
The American Medical Association (AMA) is a professional association and lobbying group of physicians and medical students. Founded in 1847, it is headquartered in Chicago, Illinois. Membership was approximately 240,000 in 2016.
The AMA's sta ...
''. Formerly known as MGA271, the drug is a humanized IgG1κ monoclonal antibody recognizing human B7-H3, a member of the B7 family of immune regulators.
This drug was developed by MacroGenics, Inc.
References
{{monoclonals for tumors
Monoclonal antibodies